# Sulforadex in Healthy Volunteers SAD

> **NCT01948362** · PHASE1 · COMPLETED · sponsor: **Evgen Pharma** · enrollment: 29 (actual)

## Conditions studied

- Stage, Prostate Cancer

## Interventions

- **DRUG:** Sulforadex
- **DRUG:** Alpha cyclodextrin

## Key facts

- **NCT ID:** NCT01948362
- **Lead sponsor:** Evgen Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2013-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01948362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01948362, "Sulforadex in Healthy Volunteers SAD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01948362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*